Sitagliptin (Januvia™) is a new oral agent approved by the US FDA to treat Type 2 diabetes. This is the first approved agent in a new class of antihyperglycemics, dipeptidyl peptidase (DPP)-4 ...

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Jimmy Investor. In this article, we will summarize ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

An orange a day, regular moderate-to-vigorous exercise, and GLP-1 drugs for diabetes treatment have all been linked to a ...

Some 85% of LTC pharmacies might limit essential services and 60% will close locations without changes to Medicare drug ...

Sign Up For Free » Here's a closer look at three discounted S&P 500 dividend stocks you can feel good about buying and ...

After hours: March 18 at 7:59:30 PM EDT Loading Chart for MRK ...

Merck (MRK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

2025年1月，美国卫生部根据《通胀削减法》（IRA）发布了第二批进入美国联邦医疗保险价格谈判的15种药品名单。这些药品包括多家跨国巨头的产品，其中司美格鲁肽尤为引人关注。本轮谈判将于今年开始，并于2027年生效。

Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Semaglutide ...

Adults with type 2 diabetes using semaglutide, dulaglutide (Trulicity, Eli Lilly), exenatide, empagliflozin (Jardiance, Boehringer Ingelheim), sitagliptin (Januvia, Merck) or glipizide from ...